TAVERNITI, VALENTINA
TAVERNITI, VALENTINA
Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente
Bacterial DNAemia is associated with serum zonulin levels in older subjects
2021-05-26 G. Gargari, G. Mantegazza, V. Taverniti, C. Del Bo', S. Bernardi, C. Andres-Lacueva, R. Gonzalez-Dominguez, P.A. Kroon, M.S. Winterbone, A. Cherubini, P. Riso, S. Guglielmetti
Bifidobacterium bifidum PRL2010 Modulates the Host Innate Immune Response
2014-01-01 F. Turroni, V. Taverniti, P. Ruas Madiedo, S. Duranti, S. Guglielmetti, G.A. Lugli, L. Gioiosa, P. Palanza, A. Margolles, D. Van Sinderen, M. Ventura
Consumption of a bifidobacterium bifidum strain for 4 weeks modulates dominant intestinal bacterial taxa and fecal butyrate in healthy adults
2016-01-01 G. Gargari, V. Taverniti, S. Balzaretti, C. Ferrario, C. Gardana, P. Simonetti, S. Guglielmetti
Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome
2020-04-18 R. Rigoni, E. Fontana, K. Dobbs, V. Marrella, V. Taverniti, V. Maina, A. Facoetti, G. D'Amico, W. Al-Herz, M.E. Cruz-Munoz, C. Schuetz, A.R. Gennery, E.K. Garabedian, S. Giliani, D. Draper, G. Dbaibo, R.S. Geha, I. Meyts, T. Tousseyn, B. Neven, D. Moshous, A. Fischer, A. Schulz, A. Finocchi, D.B. Kuhns, D.L. Fink, M.S. Lionakis, M. Swamydas, S. Guglielmetti, J. Alejo, I.A. Myles, S. Pittaluga, L.D. Notarangelo, A. Villa, B. Cassani
A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response
2010-11-01 S. Guglielmetti, V. Taverniti, M. Minuzzo, S. Arioli, I. Zanoni, M. Stuknyte, F. Granucci, M. Karp, D. Mora
Differential Modulation of Human Intestinal Bifidobacterium Populations after Consumption of a Wild Blueberry ( Vaccinium angustifolium ) Drink
2013-08-28 S. Guglielmetti, D. Fracassetti, V. Taverniti, C. Del Bo', S. Vendrame, D. Klimis Zacas, S. Arioli, P. Riso, M. Porrini
Effect of cell concentration on the persistence in the human intestine of four probiotic strains administered through a multispecies formulation
2019-01-01 V. Taverniti, R. Koirala, A. Dalla Via, G. Gargari, E. Leonardis, S. Arioli, S. Guglielmetti
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome : a pilot randomized clinical trial
2018-05-01 C. Cremon, S. Guglielmetti, G. Gargari, V. Taverniti, A.M. Castellazzi, C. Valsecchi, C. Tagliacarne, W. Fiore, M. Bellini, L. Bertani, D. Gambaccini, M. Cicala, B. Germanà, M. Vecchi, I. Pagano, M.R. Barbaro, L. Bellacosa, V. Stanghellini, G. Barbara
Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study
2020-06-01 R. Koirala, G. Gargari, S. Arioli, V. Taverniti, W. Fiore, E. Grossi, G.M. Anelli, I. Cetin, S. Guglielmetti
Evidence of dysbiosis in the intestinal microbial ecosystem of children and adolescents with primary hyperlipidemia and the potential role of regular hazelnut intake
2018-05-01 G. Gargari, V. Deon, V. Taverniti, C. Gardana, M. Denina, P. Riso, O. Guardamagna, S. Guglielmetti
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome
2018-05-11 G. Gargari, V. Taverniti, C. Gardana, C. Cremon, F. Canducci, I. Pagano, M.R. Barbaro, L. Bellacosa, A.M. Castellazzi, C. Valsecchi, S.C. Tagliacarne, M. Bellini, L. Bertani, D. Gambaccini, S. Marchi, M. Cicala, B. Germanà, E. Dal Pont, M. Vecchi, C.M. Ogliari, W. Fiore, V. Stanghellini, G. Barbara, S. Guglielmetti
Health-Promoting Properties of Lactobacillus helveticus
2012-01-01 V. Taverniti, S. Guglielmetti
Heme-oxygenase-1 production by intestinal CX3CR1+macrophages helps to resolve inflammation and prevents carcinogenesis
2017-08-01 G. Marelli, M. Erreni, A. Anselmo, V. Taverniti, S. Guglielmetti, A. Mantovani, P. Allavena
Higher bacterial DNAemia can affect the impact of a polyphenol-rich dietary pattern on biomarkers of intestinal permeability and cardiovascular risk in older subjects
2021-11-02 G. Gargari, V. Taverniti, C. Del Bo', S. Bernardi, N. Hidalgo-Liberona, T. Meroño, C. Andres-Lacueva, P.A. Kroon, A. Cherubini, P. Riso, S. Guglielmetti
Immunomodulatory effect of a wild blueberry anthocyanin-rich extract in human Caco-2 intestinal cells
2014-08-20 V. Taverniti, D. Fracassetti, C. Del Bo', C. Lanti, M. Minuzzo, D. Klimis Zacas, P. Riso, S. Guglielmetti
The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)
2011-01-01 V. Taverniti, S. Guglielmetti
Impact of a multistrain probiotic formulation with high bifidobacterial content on the fecal bacterial community and short-chain fatty acid levels of healthy adults
2020-01-01 G. Gargari, V. Taverniti, R. Koirala, C. Gardana, S. Guglielmetti
In vitro assessment of the ability of probiotics, blueberry and food carbohydrates to prevent S. pyogenes adhesion on pharyngeal epithelium and modulate immune responses
2017-01-01 V. Taverniti, A. Dalla Via, M.S. Minuzzo, C. Del Bo', P. Riso, H. Frøkiær, S.D. Guglielmetti
In Vitro Functional and Immunomodulatory Properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 Association That Are Relevant to the Development of a Pharyngeal Probiotic Product
2012-06-01 V. Taverniti, M. Minuzzo, S. Arioli, I. Junttila, S. Hämäläinen, H. Turpeinen, D. Mora, M. Karp, M. Pesu, S. Guglielmetti
Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects
2016-01-01 R. Rigoni, E. Fontana, S.D. Guglielmetti, B. Fosso, A.M. D'Erchia, V. Maina, V. Taverniti, M.C. Castiello, S. Mantero, G. Pacchiana, S. Musio, R. Pedotti, C. Selmi, J. Rodrigo Mora, G. Pesole, P. Vezzoni, P.L. Poliani, F. Grassi, A. Villa, B. Cassani